Literature DB >> 8350224

A comparison of the success rates of resident and attending strabismus surgery: discussion.

E R Crouch1.   

Abstract

Residency training involves surgery by resident surgeons at various levels of experience and proficiency, supervised by an experienced attending physician. We reviewed the results of strabismus surgery performed at four institutions with two residency training programs. Five hundred twenty-two cases with follow up greater than 6 weeks were evaluated. These cases included 315 attending procedures and 207 resident procedures under direct attending supervision. Success was defined as a strabismic deviation of 8 prism diopters or less. Average postoperative follow up was 57 weeks and did not differ between groups. There was no statistical difference between the resident success rate of 58% (121/207) and the attending success rate of 69% (217/315) after adjusting for population differences. The average final deviation of the patients postoperatively was 7 delta for the attending group and 10 delta for the resident group. Amblyopia was significantly more frequent in the resident cases (P < .001). Adjustable sutures were used significantly more often in attending cases (P < .0001). This study supports the premise that resident strabismus surgery is as successful as attending surgery. (Abstract reproduced from Wisnicki HJ, Repka MX, Raab E, et al. A comparison of the success rates of resident and attending strabismus surgery.

Entities:  

Mesh:

Year:  1993        PMID: 8350224

Source DB:  PubMed          Journal:  J Pediatr Ophthalmol Strabismus        ISSN: 0191-3913            Impact factor:   1.402


  2 in total

1.  Ruptured cerebral aneurysm: influence of specialist and trainee-performed operations on outcome.

Authors:  G Stranjalis
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

2.  Characteristics and long-term surgical outcomes of horizontal strabismus.

Authors:  Mohamad Dakroub; Dalia El Hadi; Zeinab El Moussawi; Perla Ibrahim; Christiane Al-Haddad
Journal:  Int Ophthalmol       Date:  2022-01-03       Impact factor: 2.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.